Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.
Buonadonna A, Scalone S, Lombardi D, Fumagalli A, Guglielmi A, Lestuzzi C, Polesel J, Canzonieri V, Lamon S, Giovanis P, Gagno S, Corona G, Mascarin M, Belluco C, De Paoli A, Fasola G, Puglisi F, Miolo G. Buonadonna A, et al. Among authors: guglielmi a. Cancers (Basel). 2023 Oct 18;15(20):5036. doi: 10.3390/cancers15205036. Cancers (Basel). 2023. PMID: 37894403 Free PMC article.
Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001).
Grossi F, Belvedere O, Fasola G, Barbone F, Rizzato S, Sibau A, Recchia L, Vigevani E, Ceschia T, Morelli A, Guglielmi A, Puglisi F, Follador A, Talmassons G, Sobrero AF. Grossi F, et al. Among authors: guglielmi a. Lung Cancer. 2004 Oct;46(1):99-106. doi: 10.1016/j.lungcan.2004.03.003. Lung Cancer. 2004. PMID: 15364137 Clinical Trial.
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise.
Lestuzzi C, Stolfo D, De Paoli A, Banzato A, Buonadonna A, Bidoli E, Tartuferi L, Viel E, De Angelis G, Lonardi S, Innocente R, Berretta M, Bergamo F, Guglielmi A, Sinagra G, Herrmann J. Lestuzzi C, et al. Among authors: guglielmi a. Oncologist. 2022 Mar 4;27(2):e158-e167. doi: 10.1093/oncolo/oyab035. Oncologist. 2022. PMID: 35641220 Free PMC article.
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair.
Ganzinelli M, Guffanti F, Ianza A, Sobhani N, Crovella S, Zanconati F, Bottin C, Confalonieri M, Fumagalli S, Guglielmi A, Generali D, Damia G. Ganzinelli M, et al. Among authors: guglielmi a. Cancers (Basel). 2023 Aug 29;15(17):4309. doi: 10.3390/cancers15174309. Cancers (Basel). 2023. PMID: 37686585 Free PMC article.
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience.
Ianza A, Di Chicco A, Biagi C, Giudici F, Dicorato A, Guglielmi A, Variola F, Tomasi S, Roviello G, Generali D, Zanconati F. Ianza A, et al. Among authors: guglielmi a. J Cancer Res Clin Oncol. 2021 Aug;147(8):2301-2307. doi: 10.1007/s00432-021-03658-8. Epub 2021 May 18. J Cancer Res Clin Oncol. 2021. PMID: 34003366 Free PMC article.
518 results